BioHealth News Archive
FounderTrac Demo Day
Tuesday ,November 6, 2018 6:15 PM - 8:30 PM, Hotel Annapolis126 West StreetAnnapolis, MD 21401 FounderTrac invites you to Demo Day! The FounderTrac accelerator ‘connects…
Read MoreOpGen Collaborates With QIAGEN to Advance Rapid Diagnostics for Antimicrobial Resistant Bacteria Nasdaq:OPGN
OpGen, Inc. (NASDAQ: OPGN) today announced a collaboration with QIAGEN N.V. to advance rapid diagnostics for antimicrobial resistance (AMR). Strengthening OpGen’s entry into the…
Read MoreTaiRx looks to commercialize therapy targeting drug-resistant cancers – Washington Business Journal
TaiRx, a joint venture between Rockville-based BioHealth Innovation Inc. and Taiwan pharmaceutical company TaiRx Inc., is looking to raise around $5 million. {iframe}https://www.bizjournals.com/washington/news/2018/10/31/how-maryland-s-newest-company-plans-to-take-down.html{/iframe}
Read MoreWashington Business Journal Recognizes Emmes in Two “Top Company” Lists
The Emmes Corporation today announced that it was named one of the largest women-owned businesses in the Washington metropolitan area by the Washington Business…
Read MoreHere’s how an AstraZeneca spinout deal gets done – Baltimore Business Journal
AstraZeneca PLC’s research and development arm MedImmune Inc. spun off a small biotech startup company called Viela Bio. {iframe}https://www.bizjournals.com/baltimore/news/2018/10/30/here-s-how-an-astrazeneca-spinout-deal-gets-done.html{/iframe}
Read MoreWhat’s next for RightEye following FDA approval – Washington Business Journal
Bethesda health tech company RightEye LLC is finally moving beyond the research and development phase. {iframe}https://www.bizjournals.com/washington/news/2018/10/30/righteye-got-its-fda-approval-here-s-what-s-next.html?ana=e_du_prem&s=article_du&ed=2018-10-30&u=fQFLvOpMSMnvK7iAcBsVng0eb45ba2&t=1541423895&j=84729071{/iframe}
Read MoreAlexandria Real Estate’s Marcus on Interest Rates, Drug Pricing – Bloomberg
Joel Marcus, chairman at Alexandria Real Estate Equities, discusses the risk of rising interest rates, how government action on drug pricing could impact the…
Read MoreTEDCO’s Builder Fund is closing the investment gap for more entrepreneurs – Technical.ly DC
Although we’re told business isn’t personal, the reality is that business is built on relationships. In other words, it’s not what you know, it’s…
Read MoreQIAGEN expands QIAGEN Clinical Insight software to support all major sequencing platforms and assay types
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of major enhancements to QIAGEN Clinical Insight (QCI) bioinformatics solutions to deliver…
Read MoreCEL-SCI RECEIVES ABOUT $8 MILLION FROM WARRANT EXERCISES
CEL-SCI Corporation (NYSE American: CVM) announced today it has received just under $8 million through the exercise of warrants to purchase shares of the…
Read MoreNeuralstem Announces $2.1 Million Registered Direct Offering
Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company focused on developing novel treatments for nervous system diseases, today announced that it has entered into definitive agreements…
Read MoreRegeneRx Partner Updates on Clinical Trials – Oct 29, 2018
RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the Company" or "RegeneRx"), a clinical-stage drug development company focused on tissue protection, repair and regeneration, today announced a…
Read MoreBiobuzz Directory – Epigenomics AG Obtains CE Mark for Liquid Biopsy Test for Liver Cancer Detection
Epigenomics AG (FSE: ECX, OTCQX: EPGNY) today announced that it has received CE Mark for its blood test to aid in detecting liver cancer…
Read MoreLocal entrepreneurs enter shark tank at Shore Hatchery – 47abc
The Shore Hatchery here at Salisbury University has become one of the premiere opportunities for local entrepreneurs and Friday over a dozen were making…
Read MoreAledade raises $23 million — again – Washington Business Journal
The new funding includes a $15 million investment from Palo Alto-based Meritech Capital Partners. {iframe}https://www.bizjournals.com/washington/news/2018/10/17/bethesda-health-tech-company-aledade-raises-23.html{/iframe}
Read More